SCHEMBL3234537

SCHEMBL3234537

CCOc1ccc2c(c1)C(C)(c1ccccc1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.45
MAPT P10636 3/20 0.40
RECQL P46063 2/20 0.40
LMNA P02545 2/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
PAX8 Q06710 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
USP2 O75604 2/20 0.38
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 1/20 0.37
TP53 P04637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3229236 0.92 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3234587 0.91 AVPR1A (0.46) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3236849 0.90 AVPR1A (0.45) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3226251 0.89 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3233628 0.89 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3225219 0.89 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3234170 0.88 AVPR1A (0.58) AVPR1AMAPTLMNAKMT2AMEN1
SCHEMBL3235252 0.87 AVPR1A (0.41) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3235051 0.86 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A
SCHEMBL3228428 0.86 AVPR1A (0.43) AVPR1AMAPTRECQLLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097374-B1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AS SELECTIVE LIGANDS OF V2 VASOPRESSIN RECEPTORS SANOFI AVENTIS (FR) 2010-06-09 EP claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B AVPR1A 2/4885MAPT 3330/4885RECQL 3615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.